Press Release December 1, 2021U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Merck's VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) for Use in Infants and Children 0 0 Share
Press Release December 1, 2021Merck's Pneumococcal 15-valent Conjugate Vaccine Under Priority FDA Review For Use In Kids 0 0 Share
Press Release December 1, 2021Byron Allen's $10 billion McDonald's discrimination lawsuit is thrown out 0 0 Share
Press Release December 1, 2021Dell Technologies and AWS Collaborate to Help Customers Protect their Data from Ransomware Attacks 0 0 Share
Press Release December 1, 2021Cartus reimagines its dedicated segment for new, mid-size, and growing mobility programs 0 0 Share
Press Release December 1, 2021DTEK Grids to Implement GE Digital Advanced Distribution Management System as Part of Digital Transformation Process 0 0 Share
Press Release December 1, 2021C4 Therapeutics (CCCC) Sees Hammer Chart Pattern: Time to Buy? 0 0 Share
Press Release December 1, 2021Sage Therapeutics - Biogen Share One Year Zuranolone 50mg Data In Depression Patients 0 0 Share
